Chemcon Speciality Chemicals Ltd(CHEMCON)

NSE: CHEMCONBSE: 543233

₹ 197.1-2.74%refreshed 23 Oct, 03:30 pm ISTMarket cap: ₹ 722 crWebsite: www.cscpl.comUpdated: 25 Oct 2026

About

Chemcon Speciality Chemicals makes organic chemicals such as HMDS, CMIC, Bromobenzene and 2-Bromo, plus inorganic bromides, at its plants in Manjusar, Vadodara. Its revenue was Rs 239.98 Cr in FY26. Installed capacity was 11,400 MTPA for organic chemicals and 15,000 MTPA for inorganic chemicals as of Q1 FY27.^[1][2][3]

Business segments

Organic chemicals were 75% of revenue in Q1 FY27, vs 79% in Q1 FY26 and 71% in Q4 FY26.^[2]
Inorganic chemicals fell to 13% of revenue in Q1 FY27 from 24% in Q4 FY26. 'Others' rose to 12%.^[2]
Inorganic chemicals (bromides) were about 20% of revenue in FY26, down from about 25% in FY25.^[4]

Products

The key organic products are HMDS, CMIC, Bromobenzene and 2-Bromo. The company also makes inorganic bromides and 2-bromo industrial solvents (FY25).^[3][2]
Bromobenzene and 2-Bromo are newer products. As of Q4 FY26, buyers in pharmaceuticals, agrochemicals and aromatic chemicals had responded well to them.^[4]
Bromide demand depends on oil drilling. In Q2 FY26, crude oil volatility and lower drilling activity cut bromide volumes.^[5]

Operations and capacity

Installed capacity in Q1 FY27 was 11,400 MTPA for organic chemicals across 10 operational units, and 15,000 MTPA for inorganic chemicals.^[2]
As of FY25, the company ran nine operational plants at Manjusar, Vadodara, along with warehouses for products and raw materials.^[3]
The company had 237 permanent employees as of March 31, 2025.^[3]

Sales volumes

Total volume was 2,066 MT in Q1 FY27, vs 1,972 MT in Q1 FY26.^[2]
Organic chemicals volume was 1,236 MT in Q1 FY27, vs 1,336 MT in Q1 FY26. Inorganic volume was 830 MT, vs 762 MT.^[2]
FY26 volumes were 9,991 MT in total: 5,560 MT organic and 4,431 MT inorganic.^[4]
Inorganic chemicals volume was 2,459 MT in 9M FY26, down from 4,217 MT in 9M FY25.^[6]
Q1 FY27 revenue growth came mainly from better prices across the product portfolio, not from higher volumes.^[2]

Customers and exports

Exports, including deemed exports, were about 41% of revenue in FY26, vs about 37% in FY25. Markets include the US, Europe, Japan, China, South Korea and the Middle East.^[4]
Exports were 45% of revenue in Q3 FY26 and 39% in Q2 FY26.^[6][5]
Buyers of the organic products come from the pharmaceutical, agrochemical and aromatic chemical industries (Q2 FY26).^[5]

Expansion

In the Q4 FY26 call, the company said the P-10 and P-11 organic chemicals units had been commissioned. The target date for these units had moved from Q3 FY26 to Q4 FY26.^[4][6]
In Q1 FY27, P-11 at Manjusar was listed as an upcoming facility that will add organic chemicals capacity. No commissioning date was given.^[2]
Management has named import substitution and new products or applications as growth levers (Q1 FY27).^[2]

Recent developments

In Q2 FY26, the company bought the business of related-party firm Shivam Petrochem Industries through a slump sale for Rs 36.00 crore. Shivam had FY25 turnover of about Rs 26 cr.^[5]
Shivam Petrochem adds Trityl Chloride, PTSCL, 2CTC, TosMIC and other intermediates. As of Q4 FY26, integration and licence transfers were nearly complete.^[6][4]
In Q2 and Q3 FY26, prices of key organic products were pushed down by dumping in global markets, including by Chinese producers.^[5][6]

Market Cap

₹722 Cr

High / Low

₹263 / 125

Stock P/E

25.6

Price / Book

1.5

Book Value

₹132

EPS

₹6.4

No. of Shares

3.66 Cr

ROCE

6.4%

ROE

4.8%

OPM

13.3%

Debt / Equity

0.11

Sales

₹240 Cr

Net Profit

₹24 Cr

Promoter holding

74.5%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials